Epoprostenol formulation and method of making thereof
    1.
    发明授权
    Epoprostenol formulation and method of making thereof 有权
    Eroprostenol制剂及其制备方法

    公开(公告)号:US08318802B2

    公开(公告)日:2012-11-27

    申请号:US12278061

    申请日:2007-02-02

    申请人: Naglesh R. Palepu

    发明人: Naglesh R. Palepu

    IPC分类号: A01N43/08 A61K31/34

    摘要: This invention relates to a stable epoprostenol composition that can be combined with commercially available IV fluids and can be administered in its reconstituted and/or diluted form under ambient conditions of about 15-30° C. for greater than 24 hours. The composition preferably contains (a) epoprostenol or a salt thereof; (b) a alkalinization agent; and (c) a base, such that when reconstituted or in solution, the solution has a pH>11. Methods for making the lyophilized composition are also disclosed.

    摘要翻译: 本发明涉及一种稳定的前荚MP素组合物,其可与市售IV液体组合,并且可以在约15-30℃的环境条件下以其重构和/或稀释形式施用大于24小时。 组合物优选含有(a)依前列醇或其盐; (b)碱化剂; 和(c)碱,使得当重构或溶解时,溶液的pH> 11。 还公开了制备冻干组合物的方法。